Pds Biotechnology Corp Share Price

NASDAQ: PDSB

Small Cap

$1.17

-0.01

(-1.27%)

as on September 13, 2025 at 1:29 am IST

$₹

Pds Biotechnology Corp Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$1.15
Day's Price Range
$1.2
$1.17
1.71%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
$0.85
52-Week Price Range
$4.29
$1.17
27.31%
Downside
266.67%
Upside

Pds Biotechnology Corp share price movements today

Previous Close: $1.18
Open: $1.18
Volume: 566.5K
Day's Low - High: $1.15 - $1.2
52 Week Low - High: $0.85 - $4.29

Pds Biotechnology Corp Historical Returns

1 Month Return: -2.52 %
3 Month Return: -33.71 %
1 Year Return: -61.33 %
3 Year Return: -70.41 %
5 Year Return: -53.78 %

Pds Biotechnology Corp Stock Fundamentals & Key Indicators

Check Pds Biotechnology Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$54.5M

EPS (TTM)

-0.8167

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-34.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Pds Biotechnology Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pds Biotechnology Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pds Biotechnology Corp	BUY	$54.5M	-53.78%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Pds Biotechnology Corp Stock including INR - Dollar returns

The Pds Biotechnology Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pds Biotechnology Corp investment value today

Current value as on today

₹44,139

Returns

₹55,861

(-55.86%)

Returns from Pds Biotechnology Corp Stock

₹61,000 (-61%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Pds Biotechnology Corp Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Pds Biotechnology Corp. Average target price of $7.5

Pds Biotechnology Corp Share Price Target

Get share price movements and forecasts by analysts on Pds Biotechnology Corp.

What analysts predicted

84.4%UPSIDE

Target Price

$7.5

Current Price

$1.17

Analyzed by

12 Analysts

Target

$7.50

Pds Biotechnology Corp target price $7.5, a slight upside of 84.4% compared to current price of $1.17. According to 12 analysts rating.

Pds Biotechnology Corp Stock's Interest Amongst Investors

Search interest for Pds Biotechnology Corp Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-12% versus previous 30 day period

Pds Biotechnology Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-9	-12	-10	-10	-10	-8	-10	-7	-9	-7
EBITDA	-8	-11	-9	-9	-9	-7	-9	-6	-8	-7
Interest Expense	0	0	1	1	1	1	1	1	0	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-12	-10	-10	-10	-9	-10	-7	-9	-9
Income Tax Expense	0	-1	0	0	0	0	-10,726	870	-1	-
Net Income	-9	-11	-10	-10	-10	-8	-10	-7	-8	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-13462.91%	0.00%	0.00%

Pds Biotechnology Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-39	-51	-43	-21	-14	-21	-41	-43	-36
EBITDA	-39	-51	-3	-16	-14	-21	-40	-40	-33
Interest Expense	1	2	1	0	0	0	1	4	4
Depreciation	-	0	0	0	0	0	0	0	0
Income Before Tax	-40	-53	-3	-7	-14	-21	-42	-44	-38
Income Tax Expense	-1	-2	-2	0	0	-4	-1	-1	0
Net Income	-38	-50	-40	-6	-14	-16	-40	-42	-37
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Pds Biotechnology Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-10	-10	-10	-8	-10	-7	-8	-9
Operating Cash Flow	-4	-7	-8	-9	-8	-8	-8	-9	-9
Investing Cash Flow	-	-	-	-	0	0	-28	-	-
Financing Cash Flow	0	0	10	20	0	0	0	7	0
Change in Cash	-4	-6	2	10	-8	-7	-8	-1	-8

Pds Biotechnology Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-38	-50	-40	-6	-14	-16	-40	-42	-37
Operating Cash Flow	-32	-40	-33	-18	-13	-12	-25	-33	-35
Investing Cash Flow	0	0	29	29	-	-	-	-	0
Financing Cash Flow	9	22	-20	0	29	48	34	16	20
Change in Cash	-23	-18	-53	12	16	36	8	-17	-14

Global Institutional Holdings in Pds Biotechnology Corp

Funds	Holdings
Armistice Capital, LLC	9.68%
Vanguard Group Inc	3.31%
BlackRock Inc	1.07%
Geode Capital Management, LLC	0.96%
UBS Group AG	0.55%

See all

Insights on Pds Biotechnology Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 193.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 136.9%
NEGATIVE IMPACT
Price Dip
In the last 3 months, PDSB stock has moved down by -33.7%

About Pds Biotechnology Corp

pds biotechnology is a clinical stage biopharmaceutical company developing the next-generation of simpler, safer and more effective immunotherapies for cancer and infectious diseases. pds biotechnology’s proprietary versamune® platform vector is based on synthetic and biodegradable lipids which possess a very specific structure and positive charge. the lipids form nanoparticles which activate and are taken up very efficiently by the immune system. the therapeutic product consists of versamune® formulated with a harmless form of the protein or disease-causing agent associated with the particular disease (the antigen) which our immune systems can recognize and respond to. this antigen could be a unique protein expressed only in the cancer cells and not in healthy cells, or it could be a specific viral protein(s) from an infectious virus for example. pds is in the process of completing its first phase 1 human clinical trial in 2015 for pds0101, and has initiated design and preparati

Organisation	Pds Biotechnology Corp
Headquarters	303A College Road East, Princeton, NJ, United States, 08540
Industry	Biotechnology
CEO	Dr. Frank K. Bedu-Addo Ph.D.
E-voting on shares	Click here to vote

Key Management of Pds Biotechnology Corp

Name	Title
Mr. Lars Robert Boesgaard M.B.A.	Principal Financial & Accounting Officer and CFO
Dr. Gregory L. Conn Ph.D.	Chief Scientific Officer
Mr. Spencer Brown J.D.	Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer
Ms. Janetta Trochimiuk	Controller
Dr. Frank K. Bedu-Addo Ph.D.	President, CEO & Director
Mr. Stephan Toutain M.B.A., M.S.	Chief Operating Officer
Dr. Kirk V. Shepard M.D.	Chief Medical Officer

FAQs

What is Pds Biotechnology Corp share price today?

Pds Biotechnology Corp share price today is $1.17 as on September 13, 2025 at 1:29 am IST at the close of the market. Pds Biotechnology Corp share today touched a day high of $1.2 and a low of $1.15.

What is the 52 week high and 52 week low for Pds Biotechnology Corp share?

Pds Biotechnology Corp share touched a 52 week high of $4.29 on October 3, 2024 and a 52 week low of $0.85 on April 7, 2025. Pds Biotechnology Corp stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $1.17,which is 72.73% down from its 52 week high and 37.57% up from its 52 week low.

What is Pds Biotechnology Corp's market capitalisation today?

Pds Biotechnology Corp market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Pds Biotechnology Corp Stock (PDSB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pds Biotechnology Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pds Biotechnology Corp Shares that will get you 1.2821 shares as per Pds Biotechnology Corp share price of $1.17 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Pds Biotechnology Corp Stock (PDSB) from India?

Indian investors can start investing in Pds Biotechnology Corp (PDSB) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 1:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Pds Biotechnology Corp stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 1:39 pm IST). Based on Pds Biotechnology Corp share’s latest price of $1.17 as on September 13, 2025 at 1:29 am IST, you will get 8.5470 shares of Pds Biotechnology Corp. Learn more about fractional shares .

What are the returns that Pds Biotechnology Corp has given to Indian investors in the last 5 years?

Pds Biotechnology Corp stock has given -53.78% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?